Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
R., Somasundaram, T
GLP-1 drugs were initially developed to help treat type 2 diabetes by regulating insulin release 3
Over the past several years GLP-1 receptor agonists have been developed as medications for managing diabetes, cardiovascular disease, and obesity
They framed the gutbrain axis as a dynamic bidirectional signaling network whose dysregulation underlies a broad spectrum of neurogastrointestinal diseases, positioning EVs as key mediators of intercellular communication and promising non-invasive biomarkers Derived from both host and microbial cells, EVs carry bioactive cargo, including proteins, lipids, nucleic acids, and metabolites, that reflects the physiological or pathological state of their origin and can traverse biological barriers such as the bloodbrain barrier
Intrinsic factor is a heavily glycosylated protein that is homologous to haptocorrin
US$ 27.99
US$ 21.74
)
US$ 25.11
